Genetic Biomarker Research for Personalized Therapy of Chorioretinal Neovascular Diseases
- Conditions
- Diseases of the eye and adnexa
- Registration Number
- KCT0001055
- Lead Sponsor
- Inje University Busan Paik Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
(1) Patients written consent to participate in research
(2) Patients written consent to genetic test and Research agreement
(3) Adults more than 50 years old
(4) Macular degeneration caused by chorioretinal neovascularization patients and diabetic retinopathy patients diagnosed with slit lamp examination, fundus photography, optical coherence tomography(OCT), fluorescein angiography or indocyanine angiographic.
(5) Macular degeneration caused by chorioretinal neovascularization patients and diabetic retinopathy patients not diagnosed with slit lamp examination, fundus photography, optical coherence tomography(OCT), fluorescein angiography or indocyanine angiographic.
1) Patients with soft drusen or atrophic macular degeneration not accompanied by chorioretinal neovascularization
2) difficult Patients to observe the fundus because of moderate to severe cataract
3) The possibility of pregnancy in patients.
However, No surgery for female infertility of childbearing age can participate in a clinical trial after the interview pregnancy
4) The Case legally, mentally unsuitable for participation in a clinical trial if the investigator
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease status
- Secondary Outcome Measures
Name Time Method disease progress